Cargando…
Chronic Renal Transplant Rejection and Possible Anti-Proliferative Drug Targets
The global prevalence of renal transplants is increasing with time, and renal transplantation is the only definite treatment for end-stage renal disease. We have limited the acute and late acute rejection of kidney allografts, but the long-term survival of renal tissues still remains a difficult and...
Autores principales: | Bhatti, Adnan Bashir, Usman, Muhammad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671911/ https://www.ncbi.nlm.nih.gov/pubmed/26677426 http://dx.doi.org/10.7759/cureus.376 |
Ejemplares similares
-
Quality of Life of Post-renal Transplant Patients in Rawalpindi
por: Mallick, Naafiah K, et al.
Publicado: (2022) -
Graft rejection markers in children undergoing hematopoietic cell transplant for bone marrow failure
por: Sabulski, Anthony, et al.
Publicado: (2021) -
Mast Cells in Kidney Transplant Biopsies With Borderline T Cell-mediated Rejection and Their Relation to Chronicity
por: Varol, Hilal, et al.
Publicado: (2023) -
Non-invasive approaches in the diagnosis of acute rejection in kidney transplant recipients. Part I. In vivo imaging methods
por: Hanssen, Oriane, et al.
Publicado: (2017) -
Acute Antibody-mediated Rejection Coexisting With T Cell–mediated Rejection in Pediatric ABO-incompatible Transplantation
por: Yanagi, Yusuke, et al.
Publicado: (2022)